HEALTHCARE & MEDICARE
-
Why cybersecurity is now at the heart of patient experience
As digital transformation rewrites the delivery of healthcare, patients no longer judge providers in bedside ways or even clinical outcomes.…
Read More » -
Public Health is not the Hudson River – Healthcare Blog
Gregory Hopson There is no doubt that Robert F. Kennedy, Jr. sincerely hopes to make the world a better place.…
Read More » -
Waltz Hygiene Merger to Create $6B Prescription Drug Company
Eversana is a pharmaceutical commercialization company, while digital prescription drug company Waltz Health has merged into a $6 billion entity,…
Read More » -
CDC Director was ousted after less than a month of work
Susan Monarez resigned as director of the Centers for Disease Control and Prevention after less than a month's position, making…
Read More » -
Bringing clinical data management to the cloud
Healthcare providers obtain data from many different sources: hospitals, doctors’ offices, laboratories and laboratory machines, medical equipment, pharmacies, etc. Investing…
Read More » -
How do family hospitals grow outside the country’s largest health system?
Despite the ongoing uncertainty around hospital reimbursement in the United States at the U.S., the model continues to expand but…
Read More » -
We should write a very stern letter – Healthcare Blog
Kim Bellard After the catastrophic flooding in Texas, days after Hurricane Katrina’s 20th anniversary, and Hurricane Irene has become almost…
Read More » -
Duke Spinout launches platform to unite nursing and clinical research
People across the country continue to struggle with basic health care, and nearly one-third of Americans are currently lacking primary…
Read More » -
Regeneron's RNA Med meets trial goals; plans to be planned for next year's FDA filing
Recovery drugs that reduce disease kinesin levels meet the goals of key tests in rare diseases. Based on these results,…
Read More » -
LB Pharma prepares for IPO funding 3-phase test with new schizophrenia drug
Many drugs can be used for schizophrenia, but the efficacy and intolerable side effects are insufficient, so biotech companies are…
Read More »